Review summary
Teaching objective: Confirm COPD with post-bronchodilator spirometry in an 82-year-old former smoker who quit about thirty years ago, classify it by GOLD 2025 (grade 3, group B) with the CAT, mMRC, and exacerbation history, start a long-acting bronchodilator pair in an inhaler he can use well, check blood eosinophils and alpha-1 antitrypsin, assess oxygen need at rest and on exertion, enroll him in pulmonary rehabilitation, bring vaccines up to date, explain why he is not eligible for lung cancer screening, screen for comorbidities and mood, and begin advance care planning, on the CMID COPD schedule.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| March 26, 1931 | Born in Boston. | CLM-0001 |
| 1966 | Begins three seasons as Mr. Spock in Star Trek; later acts and directs in film. | CLM-0002 |
| about 1984 | Quits smoking, by his own account about thirty years before his 2014 announcement. | CLM-0003 |
| January 2014 | Announces publicly that he has COPD and urges smokers to quit. | CLM-0003, CLM-0005 |
| February 2014 | Says he cannot walk distances; seen at an airport in a wheelchair. | CLM-0004 |
| February 12, 2014 | Writes that an attempt to smoke a little failed and that he quit through a program; in March, that addiction made him ignore medical advice. | CLM-0006 |
| February 27, 2015 | Died at home in Los Angeles; cause reported as end-stage COPD. | CLM-0007, CLM-0008 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Leonard Nimoy was born in Boston on March 26, 1931. | confirmed | Leonard Nimoy, Spock of 'Star Trek,' dies at 83 (Associated Press) supports |
| D | He played Mr. Spock in the Star Trek television series from 1966 to 1969, later acted in and directed Star Trek films, and directed other films, including the comedy Three Men and a Baby. Used for the synthetic modern occupation. |
confirmed | Leonard Nimoy, Spock of 'Star Trek,' dies at 83 (Associated Press) supports |
| D | In a Twitter post at the end of January 2014 he announced that he had chronic obstructive pulmonary disease: "I quit smoking 30 yrs ago. Not soon enough. I have COPD. Grandpa says, quit now!! LLAP". His own public disclosure of COPD and of having quit smoking about 30 years earlier. ABC News dates the post January 29 and TODAY dates it January 30; the case uses late January. |
confirmed | Fisher L. Leonard Nimoy Reveals He Has Lung Disease supports Diagnosed with COPD, Leonard Nimoy urged people to quit smoking supports |
| D | In early February 2014 he posted "I'm doing OK. Just can't walk distances," and ABC News reported that he had been seen at an airport in a wheelchair. His own public description of exertional limitation; used for the presenting concern. |
confirmed | Fisher L. Leonard Nimoy Reveals He Has Lung Disease supports Diagnosed with COPD, Leonard Nimoy urged people to quit smoking supports |
| D | In February 2014 he urged smokers to quit: "Smokers, please understand. If you quit after you're diagnosed with lung damage it's too late." | confirmed | Fisher L. Leonard Nimoy Reveals He Has Lung Disease supports |
| D | Later in February 2014 he wrote that he had tried to "smoke a little," had failed, and had learned he could not smoke at all, that quitting was not easy and he had gone through a program; in March 2014 he wrote that when he was addicted to cigarettes he ignored good medical advice. His own public account of tobacco dependence and of quitting through a program. Posted after the index date; recorded in the claims only. |
confirmed | Diagnosed with COPD, Leonard Nimoy urged people to quit smoking supports |
| D | At his death UPI reported that he had had COPD for over a year, that the disease resulted from years of smoking, and that he had called himself an "Olympic championship smoker" in a television interview. News summary at his death; the length of his illness before the January 2014 disclosure is not otherwise documented. |
probable | Actor, artist and philanthropist Leonard Nimoy dies at 83 supports |
| D | He died at his home in Los Angeles on February 27, 2015, at 83; news reports citing his family gave the cause as end-stage chronic obstructive pulmonary disease. Cause of death as reported publicly; recorded without further detail. |
confirmed | Actor, artist and philanthropist Leonard Nimoy dies at 83 supports Leonard Nimoy, Spock of 'Star Trek,' dies at 83 (Associated Press) supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Chronic obstructive pulmonary disease, GOLD 3 (severe airflow limitation), group B, confirmed on spirometry; synthetic modern classification linked to his publicly disclosed COPD | active | confirmed | both_with_link | CLM-0003, CLM-0004, CLM-0007 |
| S | Former smoker, quit about 30 years ago through a cessation program | active | confirmed | both_with_link | CLM-0003, CLM-0006 |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 2026-02-10 | FEV1 --pre bronchodilation | 1.18 L (low) Reference >=1.95 L |
http://loinc.org · 20157-4 |
| S | 2026-02-10 | FEV1 --post bronchodilation | 1.26 L (low) Reference >=1.95 L |
http://loinc.org · 20155-8 |
| S | 2026-02-10 | FEV1 measured/predicted | 46% (low) Reference >=80% |
http://loinc.org · 20152-5 |
| S | 2026-02-10 | Forced vital capacity [Volume] Respiratory system --post bronchodilation | 2.93 L Reference >=2.75 L |
http://loinc.org · 19875-4 |
| S | 2026-02-10 | FEV1/FVC --post bronchodilation | 0.43 (low) Reference GOLD fixed ratio 0.70; post-bronchodilator ratio below 0.70 confirms airflow obstruction |
http://loinc.org · 69970-2 |
| S | 2026-02-10 | Eosinophils [#/volume] in Blood by Automated count | 0.18 10*3/uL Reference 0-0.5 10*3/uL |
http://loinc.org · 711-2 |
| S | 2026-02-10 | Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma | 138 mg/dL Reference 90-200 mg/dL |
http://loinc.org · 1825-9 |
| S | 2026-02-10 | Hemoglobin [Mass/volume] in Blood | 14.6 g/dL Reference 13.5-17.5 g/dL |
http://loinc.org · 718-7 |
| S | 2026-02-10 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 mg/dL Reference 0.7-1.3 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-02-10 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | http://loinc.org · 44261-6 |
| S | 2026-03-10 | Six minute walk test | 270 m (low) Reference Predicted about 480 m for his age, sex, height, and weight; lower limit about 380 m |
http://loinc.org · 64098-7 |
| S | 2026-05-12 | Six minute walk test | 330 m (low) Reference Predicted about 480 m for his age, sex, height, and weight; lower limit about 380 m |
http://loinc.org · 64098-7 |
| S | 2026-10-06 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | http://loinc.org · 55758-7 |
| S | 2026-10-06 | Total score [Mini-Cog] | 5 | http://loinc.org · 72233-0 |
| S | 2026-10-06 | Total score [AUDIT-C] | 0 | http://loinc.org · 75626-2 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 2026-02-10 | Body height | 185 cm | 8302-2 | S |
| 2026-02-10 | Body weight | 80 kg | 29463-7 | S |
| 2026-02-10 | Body mass index (BMI) [Ratio] | 23.4 kg/m2 | 39156-5 | S |
| 2026-02-10 | Systolic blood pressure | 132 mm[Hg] | 8480-6 | S |
| 2026-02-10 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 2026-02-10 | Heart rate | 84 /min | 8867-4 | S |
| 2026-02-10 | Respiratory rate | 20 /min | 9279-1 | S |
| 2026-02-10 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-02-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 93 % | 59408-5 | S |
| 2026-03-10 | Body height | 185 cm | 8302-2 | S |
| 2026-03-10 | Body weight | 80.2 kg | 29463-7 | S |
| 2026-03-10 | Body mass index (BMI) [Ratio] | 23.4 kg/m2 | 39156-5 | S |
| 2026-03-10 | Systolic blood pressure | 128 mm[Hg] | 8480-6 | S |
| 2026-03-10 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 2026-03-10 | Heart rate | 82 /min | 8867-4 | S |
| 2026-03-10 | Respiratory rate | 18 /min | 9279-1 | S |
| 2026-03-10 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-03-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 93 % | 59408-5 | S |
| 2026-05-12 | Body height | 185 cm | 8302-2 | S |
| 2026-05-12 | Body weight | 80.8 kg | 29463-7 | S |
| 2026-05-12 | Body mass index (BMI) [Ratio] | 23.6 kg/m2 | 39156-5 | S |
| 2026-05-12 | Systolic blood pressure | 126 mm[Hg] | 8480-6 | S |
| 2026-05-12 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 2026-05-12 | Heart rate | 78 /min | 8867-4 | S |
| 2026-05-12 | Respiratory rate | 18 /min | 9279-1 | S |
| 2026-05-12 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-05-12 | Oxygen saturation in Arterial blood by Pulse oximetry | 94 % | 59408-5 | S |
| 2026-08-11 | Body height | 185 cm | 8302-2 | S |
| 2026-08-11 | Body weight | 81 kg | 29463-7 | S |
| 2026-08-11 | Body mass index (BMI) [Ratio] | 23.7 kg/m2 | 39156-5 | S |
| 2026-08-11 | Systolic blood pressure | 128 mm[Hg] | 8480-6 | S |
| 2026-08-11 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 2026-08-11 | Heart rate | 76 /min | 8867-4 | S |
| 2026-08-11 | Respiratory rate | 18 /min | 9279-1 | S |
| 2026-08-11 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-08-11 | Oxygen saturation in Arterial blood by Pulse oximetry | 94 % | 59408-5 | S |
| 2026-10-06 | Body height | 185 cm | 8302-2 | S |
| 2026-10-06 | Body weight | 80.6 kg | 29463-7 | S |
| 2026-10-06 | Body mass index (BMI) [Ratio] | 23.6 kg/m2 | 39156-5 | S |
| 2026-10-06 | Systolic blood pressure | 130 mm[Hg] | 8480-6 | S |
| 2026-10-06 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 2026-10-06 | Heart rate | 76 /min | 8867-4 | S |
| 2026-10-06 | Respiratory rate | 18 /min | 9279-1 | S |
| 2026-10-06 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-10-06 | Oxygen saturation in Arterial blood by Pulse oximetry | 94 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Former smoker: smoked cigarettes heavily for about 25 years, about 40 pack-years by his estimate, and quit about 30 years ago through a cessation program; no tobacco, vaping, or cannabis since; no alcohol; no other drug use
- S Actor and director, now working part time on photography, writing, and voice projects; married and lives with his spouse in a single-story home
- S Walks about 10 minutes at a time around the house and garden; uses a wheelchair for long distances such as airports
- S No occupational dust or fume exposure; no biomass or wood-stove exposure; no pets
- S Supports: spouse, adult children, long-time friends and colleagues; wants to use his experience to persuade smokers to quit
Functional status
- S At intake, stops for breath after about 100 meters on level ground (mMRC grade 3); CAT score 22; independent in self-care
- S After pulmonary rehabilitation, walks about 300 meters at his own pace before stopping (mMRC grade 2); CAT score 15 at three months and 14 at six months
Mental status
- S Alert, articulate, and dryly humorous; asks precise questions about his test results
- S Mood steady; PHQ-9 score 3; GAD-2 score 1
Allergies and medications
Allergies
- S No known allergy
Medications
- S Albuterol 90 mcg/actuation inhaler, two inhalations as needed for breathlessness (prescribed by his previous clinician; used once or twice most days before intake)
- S Tiotropium-olodaterol 2.5/2.5 mcg soft mist inhaler, two inhalations once daily
Procedures and immunizations
Procedures
- S Spirometry before and after albuterol 400 mcg: FEV1 1.18 L before and 1.26 L after bronchodilator (46 percent predicted), FVC 2.93 L, FEV1/FVC 0.43 after bronchodilator
- S 12-lead ECG: sinus rhythm at 84 per minute, normal axis and intervals, no ischemic change or right heart strain
- S Outpatient pulmonary rehabilitation, 24 supervised sessions over eight weeks (endurance and strength training, breathing techniques, inhaler and self-management education)
- S Advance care planning conversation, about 25 minutes
Immunizations
- S 2025-10-07: High-dose influenza vaccine, 2025-2026 season
- S 2019-04-16: Recombinant zoster vaccine, two-dose series completed
- S 2018-05-22: Tdap vaccine
- S 2026-05-12: Pneumococcal conjugate vaccine PCV20
- S 2026-10-06: High-dose influenza vaccine, 2026-2027 season
- S 2026-10-06: RSV vaccine, single dose
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- D about 1984: Former smoker who quit about thirty years before the index visit (CLM-0003)
- D January 2014: Chronic obstructive pulmonary disease, disclosed publicly in late January, with breathlessness that keeps him from walking distances (CLM-0003, CLM-0004)
Family history
No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| CAT score at least 2 points lower by the three-month review | 2026-05-12 | completed | CAT fell from 22 to 15 |
| 6-minute walk distance at least 30 meters farther after pulmonary rehabilitation | 2026-05-12 | completed | 270 m at entry and 330 m at exit |
| No moderate or severe exacerbation over the six months after starting maintenance therapy | 2026-08-11 | completed | No exacerbation, oral corticosteroid course, antibiotic course, or emergency visit in six months |
| Correct soft mist inhaler technique and a daily maintenance dose | 2026-03-10 | completed | Correct technique on demonstration and no missed doses by dose counter at four weeks |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Start tiotropium-olodaterol 2.5/2.5 mcg soft mist inhaler, two inhalations each morning, keep albuterol as needed, and teach and check inhaler technique at every visit; no inhaled corticosteroid while there are no exacerbations and blood eosinophils are below 300 per microliter | completed | GL-GOLD-2025, GL-CMID-2026 |
| Pulmonology consultation to confirm the GOLD grade and group, review the inhaler choice and the place of an inhaled corticosteroid, assess oxygen need at rest and on exertion, interpret the alpha-1 antitrypsin result, and advise on pulmonary rehabilitation and lung cancer screening | completed | GL-GOLD-2025, GL-CMID-2026 |
| Outpatient pulmonary rehabilitation (mMRC 2 or more, GOLD 2 to 4), with a 6-minute walk test at entry and exit and a home exercise plan afterwards | completed | GL-ATS-PR-2023, GL-GOLD-2025, GL-CMID-2026 |
| At every visit: CAT, mMRC, exacerbations in the past 12 months, GOLD group, pulse oximetry, smoking status, BMI, and inhaler technique. Spirometry at diagnosis and at least yearly; alpha-1 antitrypsin once; blood eosinophils at baseline and before any change in inhaled corticosteroid; arterial blood gas only if resting saturation is 92 percent or less; long-term oxygen only for resting saturation of 88 percent or less confirmed twice at least three weeks apart; ECG and cardiovascular risk at baseline | completed | GL-CMID-2026, GL-GOLD-2025, GL-ATS-LTOT-2020 |
| Written COPD action plan: what an exacerbation looks like (more breathlessness, more or discolored sputum), when to use extra albuterol, and when to call the clinic the same day or go to emergency care | completed | GL-GOLD-2025, GL-CMID-2026 |
| Lung cancer screening reviewed and not offered: he quit smoking more than 15 years ago, so he does not meet the USPSTF criteria despite more than 20 pack-years | completed | GL-USPSTF-LUNG-2021, GL-CMID-2026 |
| Vaccines for COPD: yearly influenza (high dose at 65 and older), PCV20 once, RSV once at 75 and older, COVID-19 by CDC guidance, Tdap every ten years, and recombinant zoster | completed | GL-CMID-2026, GL-CDC-IMZ-2026 |
| Comorbidity and mood screening at intake and yearly (depression, anxiety, cardiovascular disease, osteoporosis, reflux, sleep, nutrition), and advance care planning at the wellness visit | completed | GL-GOLD-2025, GL-CMID-2026 |
Planned encounters
- 2026-02-10 — New patient visit for COPD and breathlessness walking any distance (ENC-001)
- 2026-03-10 — Four-week COPD review after starting dual bronchodilator therapy, with pulmonology consultation (ENC-002)
- 2026-05-12 — Three-month COPD review after pulmonary rehabilitation (ENC-003)
- 2026-08-11 — Six-month COPD review (ENC-004)
- 2026-10-06 — Subsequent annual wellness visit (ENC-005)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Focused Visit (Follow-up)
- Progress note 04 — Focused Visit (Care-plan review)
- Progress note 05 — Annual Wellness Visit, Subsequent
- Pulmonology referral
- Pulmonology consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Focused Visit (Follow-up) (XML)
- Progress note 04 — Focused Visit (Care-plan review) (XML)
- Progress note 05 — Annual Wellness Visit, Subsequent (XML)
- Pulmonology referral (XML)
- Pulmonology consultation (XML)
Sources
| ID | Source | Publisher | Type |
|---|---|---|---|
| SRC-0001 | Fisher L. Leonard Nimoy Reveals He Has Lung Disease | ABC News | other |
| SRC-0002 | Diagnosed with COPD, Leonard Nimoy urged people to quit smoking | TODAY (NBC News) | other |
| SRC-0003 | Actor, artist and philanthropist Leonard Nimoy dies at 83 | United Press International | other |
| SRC-0004 | Leonard Nimoy, Spock of 'Star Trek,' dies at 83 (Associated Press) | The Atlanta Journal-Constitution | other |
| SRC-0005 | HISTMED Master Roster v3 | The Human Record project | other |
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check the GOLD grade and group, the inhaler choice, the oxygen assessment, and the deviation recorded for the delayed pneumococcal vaccine. |
| provenance review | not_started | Recent-death rule: only his own public posts and statements, as reported by ABC News, TODAY, UPI, and the Associated Press, and the publicly reported cause of death are used. No spirometry, treatment, or hospital detail from his lifetime is used. |
| safe messaging review | not_started | Tobacco claims are marked sensitive; no behavioral-health diagnosis; the final hospital stay is not used; death recorded without detail. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.